What is HERmark?

HERmark is an assay that precisely measures HER-2 total protein expression in patients with breast cancer. Clinical studies demonstrate that HERmark is an accurate method for stratifying patients with breast cancer who are more likely to respond to trastuzumab-containing therapy.

Weight: 
-26